Clinical Trials Directory

Trials / Conditions / HPV Vaccine

HPV Vaccine

17 registered clinical trials studyying HPV Vaccine8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Randomized Trial of Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers
NCT07498075
University of PennsylvaniaN/A
Not Yet RecruitingStrengthening HPV Immunization Through EPI Leveraged Delivery
NCT07377656
International Vaccine InstitutePhase 2
Not Yet RecruitingEvaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy
NCT07200570
Fudan UniversityN/A
RecruitingPersistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
NCT07156084
Canadian Immunization Research NetworkPhase 4
RecruitingHPV Ends Here: Increasing Uptake of the HPV Vaccine
NCT06831929
University of California, DavisN/A
Not Yet RecruitingImpact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment
NCT06405048
Fudan UniversityN/A
RecruitingEffectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China
NCT06227689
Fudan UniversityN/A
Not Yet RecruitingTwo Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
NCT06137352
Fujian Maternity and Child Health Hospital
UnknownPrevalence of ENT Diseseas
NCT06105346
Medical University of Graz
Active Not RecruitingImmunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871
University of WashingtonPhase 4
CompletedHPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
NCT04982614
Columbia UniversityPhase 4
CompletedAdaptation Of An HPV Education Resource To Promote HPV Vaccination
NCT04974619
H. Lee Moffitt Cancer Center and Research Institute
CompletedMobile Coaching to Improve HPV Vaccine Delivery
NCT05105711
UNC Lineberger Comprehensive Cancer CenterN/A
Active Not RecruitingIntradermal, Fractional Dose of HPV Vaccines:
NCT04235257
University of WashingtonPhase 4
UnknownRetrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus
NCT04171505
Hospital San Carlos, Madrid
CompletedState Immunization Information Systems to Improve HPV Vaccination Rates
NCT02993965
University of Colorado, DenverN/A
CompletedAntibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys
NCT04711265
Kenya Medical Research Institute